Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

News Industry News

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

April 11, 2018

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

Michael O'Riordan

November 02, 2016

News Daily News

一项小规模OCT研究发现，对生物吸收支架的长期反应是有益的

December 04, 2014

News Daily News

Un Pequeño Estudio OCT Sugiere una Respuesta Favorable a Largo Plazo al Andamiaje Bioabsorbible

December 04, 2014

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

Presentation

OCT Assessment of the Long-term Vascular Healing Response 5 Years After Everolimus-Eluting BVS

Presenter: A. Karanasos

December 02, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Jason Kahn

January 27, 2014

Presentation TCT 2012

TCT-17. Serial Changes of Everolimus-Eluting Stent Malapposition: An Optical Coherence Tomography Subanalysis from the RESET Trial

Presenter: Kunihiro Shimamura

October 23, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

Advertisement

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Uncomplicated TLR After PCI Linked With Worse Mortality

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

一项小规模OCT研究发现，对生物吸收支架的长期反应是有益的

Un Pequeño Estudio OCT Sugiere una Respuesta Favorable a Largo Plazo al Andamiaje Bioabsorbible

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

OCT Assessment of the Long-term Vascular Healing Response 5 Years After Everolimus-Eluting BVS

Stent Malapposition Frequent, But Without Clinical Consequences

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

TCT-17. Serial Changes of Everolimus-Eluting Stent Malapposition: An Optical Coherence Tomography Subanalysis from the RESET Trial

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content